InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
0.281
-0.009 (-3.24%)
At close: Sep 12, 2024, 4:00 PM
0.270
-0.011 (-3.78%)
Pre-market: Sep 13, 2024, 8:48 AM EDT
InMed Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2014 |
| Revenue | 5.63 | 4.14 | 1.09 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 140.49% | 279.61% | - | - | - | - | Upgrade
|
| Cost of Revenue | 3.42 | 2.73 | 0.55 | - | - | - | Upgrade
|
| Gross Profit | 2.21 | 1.4 | 0.54 | - | - | - | Upgrade
|
| Selling, General & Admin | 5.45 | 5.85 | 6.67 | 4.48 | 3.23 | 3.8 | Upgrade
|
| Research & Development | 3.18 | 3.73 | 7.28 | 5.34 | 5.81 | 5.64 | Upgrade
|
| Operating Expenses | 8.85 | 9.78 | 14.14 | 9.94 | 9.15 | 13.64 | Upgrade
|
| Operating Income | -6.64 | -8.38 | -13.59 | -9.94 | -9.15 | -13.64 | Upgrade
|
| Interest & Investment Income | 0.57 | 0.49 | 0.1 | 0.02 | 0.13 | 0.43 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.05 | -0.12 | -0.16 | 0.08 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.12 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -6.07 | -7.93 | -13.61 | -10.2 | -8.94 | -13.26 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.2 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | -2.02 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -1.45 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -1.31 | - | - | - | Upgrade
|
| Pretax Income | -6.07 | -7.93 | -18.6 | -10.2 | -8.94 | -13.26 | Upgrade
|
| Income Tax Expense | 0 | 0.01 | - | - | - | - | Upgrade
|
| Net Income | -6.08 | -7.95 | -18.6 | -10.2 | -8.94 | -13.26 | Upgrade
|
| Net Income to Common | -6.08 | -7.95 | -18.6 | -10.2 | -8.94 | -13.26 | Upgrade
|
| Shares Outstanding (Basic) | 6 | 2 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 2 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 240.38% | 336.58% | 108.65% | 28.72% | 0.84% | 19.94% | Upgrade
|
| EPS (Basic) | -1.00 | -3.25 | -33.17 | -37.96 | -42.81 | -64.01 | Upgrade
|
| EPS (Diluted) | -1.01 | -3.25 | -33.17 | -37.96 | -42.81 | -64.01 | Upgrade
|
| Free Cash Flow | -6.66 | -7.45 | -15.62 | -9.79 | -7.42 | -8.8 | Upgrade
|
| Free Cash Flow Per Share | -1.10 | -3.04 | -27.86 | -36.43 | -35.52 | -42.51 | Upgrade
|
| Gross Margin | 39.20% | 33.93% | 49.89% | - | - | - | Upgrade
|
| Operating Margin | -118.06% | -202.60% | -1247.60% | - | - | - | Upgrade
|
| Profit Margin | -108.01% | -192.18% | -1707.32% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -118.34% | -180.02% | -1434.03% | - | - | - | Upgrade
|
| EBITDA | -6.42 | -8.18 | -13.41 | -9.82 | -9.04 | -13.52 | Upgrade
|
| EBITDA Margin | -114.18% | -197.71% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.22 | 0.2 | 0.19 | 0.12 | 0.11 | 0.12 | Upgrade
|
| EBIT | -6.64 | -8.38 | -13.59 | -9.94 | -9.15 | -13.64 | Upgrade
|
| EBIT Margin | -118.06% | -202.60% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.